U.S. Markets closed

GABY Inc. (GABLF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.04600.0000 (0.00%)
At close: 12:23PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0460
Open0.0324
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0324 - 0.0470
52 Week Range0.0200 - 0.2910
Volume32,000
Avg. Volume16,064
Market Cap7.96M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0840
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • ACCESSWIRE

    GABY Advises Further on Filing of Fiscal 2019 and 2020 Q1 Results

    SANTA ROSA, CA and CALGARY, AB / ACCESSWIRE / July 31, 2020 / GABY Inc.

  • ACCESSWIRE

    Company Advises on Filing of Fiscal 2019 and 2020 Q1 Results

    SANTA ROSA, CA and CALGARY, AB / ACCESSWIRE / July 3, 2020 / GABY Inc. ("GABY" or the "Company") (CSE:GABY)(OTCQB:GABLF), a California based consumer packaged goods company using cannabinoids (whole plant, isolates and distillates) as foundational ingredients in a range of wellness oriented branded products sold in both the regulated cannabis and unlicensed retail sectors across California and direct to consumers, provides an update with respect to the management cease trade order (the "MCTO") issued by the Alberta Securities Commission on June 17, 2020. The MCTO was issued in connection with the filing of its annual financial statements, management's discussion and analysis and related officer certifications for the financial year ended December 31, 2019 (collectively the "Annual Filings").

  • ACCESSWIRE

    Company Provides Update on Operations: Cuts Approximately $5,000,000 in Annualized Costs - Advises on Filing of Fiscal 2019 and 2020 Q1 Results

    SANTA ROSA, CA and CALGARY, AB / ACCESSWIRE / June 3, 2020 / GABY Inc. ("GABY" or the "Company") (CSE:GABY)(OTCQB:GABLF), a California based consumer packaged goods company using cannabinoids (whole plant, isolates and distillates) as foundational ingredients in a range of wellness oriented branded products sold in both the regulated cannabis and unlicensed retail sectors across California and direct to consumers, is pleased to provide an update of its current operations and provide a timeline for the release of its Fiscal 2019 and 2020 Q1 financial results. In support of ongoing efficiencies and margin expansion GABY has restructured its operations, refocusing its efforts exclusively in California, shedding low margin divisions, creating operational efficiencies, lowering costs, and simplifying the business structure.